Investing.com -- Barclays (LON:BARC) downgraded Rémy Cointreau (EPA:RCOP) to “underweight” from “equal weight,” citing the ...

Barclays (LON: BARC) views the development as “a small negative for Bayer,” though analysts remain positive on the drug’s ...

Investing.com -- Maia Biotechnology Inc (NYSE: MAIA) stock surged 11.2% in pre-market trading after the company announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track ...

Amazon (NASDAQ: AMZN) stock rose 0.7% after Jefferies stated that the impact of sweeping U.S. tariffs on the e-commerce giant appear to be "overstated for now," as it remains a "go-to destination" for ...

Investing.com -- Nvidia’s inventory of H20 AI chips is unlikely to satisfy surging demand in China following a temporary lift of U.S. export restrictions, according to Jefferies. The firm estimates ...

Investing.com -- Morgan Stanley equity strategist Michael Wilson believes the S&P 500 could rally to 7,200 by mid-2026, citing a “rolling recovery” in earnings and supportive macro trends. “We’re ...

Investing.com - Elevated U.S. tariffs could spark inflation that will slow spending more for lower income cohorts than those making top-end salaries, according to analysts at Morgan Stanley (NYSE: MS ...

CervoMed Inc. (NASDAQ:CRVO) stock rose 30% after the company reported positive 32-week data from its RewinD-LB trial showing that its experimental drug neflamapimod significantly slowed clinical ...